Portal de investigación
CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD.
Datos básicos
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
A novel pan-PPAR agonist (BP-2) normalizes metabolic and inflammatory parameters in vitro and in ob/ob mice
Meeting Abstract. 2023
Association of chemokines IP-10/CXCL10 and I-TAC/CXCL11 with insulin resistance and enhance leukocyte endothelial arrest in obesity.
Moreno, Beatriz; (...); Real, Jose T
Article. 10.1016/j.mvr.2021.104254. 2022
CXCL16/CXCR6 axis arises as a potential peripheral biomarker of early COPD development - results from a pilot study
Marques P; (...); Sanz MJ
Article. 10.3389/fmed.2025.1636360. 2025
Platelet hyperactivity as a trigger of platelet-leukocyte-endothelium interactions and subsequent cardiovascular complications in early-stage COPD
Marques, P; (...); Sanz, MJ
Meeting Abstract. 2023
Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction.
Rios-Navarro, Cesar; (...); Bodi, Vicente
Article. 10.1016/j.rec.2020.03.013. 2021
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonism inhibits leukocyte adhesiveness to dysfunctional endothelium
Marques, P; (...); Piqueras, L
Meeting Abstract. 2023
The nuclear retinoid-related orphan receptor RORa controls adipose tissue inflammation in patients with morbid obesity and diabetes.
Ortega, Rebeca; (...); Piqueras, Laura
Article. 10.1038/s41366-021-00787-5. 2021
